netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 19 of 19


Details
UPD Published from Draft Mode
26/03/2024 11:22:41
(LoweryM )
UPD sitematrix Changed from 0 to
26/03/2024 11:22:37
(LoweryM )
UPD Loperamide published
26/03/2024 11:22:37
(LoweryM )
UPD sitematrix Changed from 0 to
11/03/2024 11:58:05
(LoweryM )
UPD FurtherInformation Changed from
11/03/2024 11:58:05
(LoweryM )
UPD Loperamide approved
11/03/2024 11:58:05
(LoweryM )
UPD sitematrix Changed from 0 to
11/03/2024 11:53:03
(DavidS )
UPD FurtherInformation Changed from
  • 2mg capsules
  • 2mg Orodispersible tablets: approved for use in primary care following specialist initiation in secondary care for patients with high output stoma only.
11/03/2024 11:53:03
(DavidS )
UPD Loperamide amended
11/03/2024 11:53:03
(DavidS )
UPD sitematrix Changed from 0 to
11/03/2024 11:49:26
(DavidS )
UPD isDraft Changed from N to Y
11/03/2024 11:49:26
(DavidS )
UPD FurtherInformation Changed from to
  • 2mg capsules
  • 2mg Orodispersible tablets: approved for use in primary care following specialist initiation in secondary care for patients with high output stoma only.
11/03/2024 11:49:26
(DavidS )
UPD Drug Description Changed from Loperamide 2mg Capsules to Loperamide
11/03/2024 11:49:26
(DavidS )
UPD Loperamide amended to now show loperamide as one entry with capsule and orodispersible
11/03/2024 11:49:26
(DavidS )
LDL Link Added : MHRA Drug Safety Alert Sept 2017: Loperamide (Imodium): Reports of serious cardiac adverse reactions with high doses of loperamide associated with abuse or misuse : https://www.gov.uk/drug-safety-update/loperamide-imodium-reports-of-serious-c
07/07/2023 08:41:32
(ebeavers )
UPD Published from Draft Mode
09/01/2017 16:52:53
(LoweryM )
UPD Loperamide 2mg Capsules build
09/01/2017 16:51:37
(LoweryM )
UPD Loperamide 2mg Capsules build
09/01/2017 16:51:12
(LoweryM )
DUP Loperamide 2mg Capsules build
09/01/2017 16:48:41
(LoweryM )

 

 

netFormulary